Clinical Pharmacokinetics of the Androgen Receptor Inhibitor Darolutamide in Healthy Subjects and Patients with Hepatic or Renal Impairment
The above audio feature represents the opinions of the authors. For a full list of
declarations, including funding and author disclosure statements, please see
the full text online (see “read the peer-reviewed publication” opposite).© The authors, CC-BY-NC 2021.